Crinetics Pharmaceuticals, Inc.
CRNX
Revenue
399.00k
▼-241.00k▼-37.66%
3 Months ChangeAssets
935.54M
▼-42.62M▼-4.36%
3 Months ChangeLiabilities
104.77M
▲1.55M▲1.50%
3 Months ChangeFree Cash Flow
-54.19M
▼-13.45M▼-33.03%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-16
Form 8-K
ID: 0001193125-24-238120
2024-10-09
Form 8-K
ID: 0001193125-24-235275
2024-09-26
Form 8-K
ID: 0000950170-24-109644
2024-09-17
Form 8-K
ID: 0000950170-24-107259
2024-08-08
Form 10-Q
ID: 0000950170-24-093977
2024-08-08
Form 8-K
ID: 0000950170-24-093951
2024-06-21
Form 8-K
ID: 0001193125-24-165903
2024-06-10
Form 8-K
ID: 0000950170-24-071354
2024-06-03
Form 8-K
ID: 0001193125-24-153075
2024-05-22
Form 8-K
ID: 0001193125-24-144484